News | May 10, 2021
Sun Pharma signs agreement with Eli Lilly for expanding access to Baricitinib
Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19
Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19
Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19
Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.
Candid Powder brand is a market-leader in its category, with a market share of 64% in the medicated powder category.
The commercial production in the SML was started in November 1989.
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The biggest highlight was Project Vimana, a drone-deployed battlefield trauma surgery system engineered to bring life-saving surgical intervention
Subscribe To Our Newsletter & Stay Updated
